| Kisiel, John |
Mayo Clinic Rochester
United States |
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation |
5R37CA214679-07 |
|
Matthew Young, Ph.D. |
| Abrams, Julian |
Columbia University Health Sciences
United States |
The Oral Microbiome for the Detection of Barretts Esophagus |
5R01CA238433-05 |
|
Matthew Young, Ph.D. |
| Iyer, Prasad G. |
Mayo Clinic Rochester
United States |
Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma |
5R01CA241164-05 |
|
Matthew Young, Ph.D. |
| Zhu, Yazhen |
University Of California Los Angeles
United States |
Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma |
5R01CA255727-04 |
|
Matthew Young, Ph.D. |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using Markers to Improve Pancreatic Cancer Screening |
5R01CA176828-09 |
|
Matthew Young, Ph.D. |
| Iyer, Prasad G. |
Mayo Clinic Rochester
United States |
Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma |
5R01CA241164-05 |
|
Matthew Young, Ph.D. |
| Hruska, Carrie B |
Mayo Clinic Rochester
United States |
Density MATTERS Clinical Trial |
5R01CA239200-04 |
|
Claire Zhu, Ph.D. |
| Watt, Gordon Patrick |
Sloan-Kettering Inst Can Research
United States |
Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk |
1R37CA284134-01A1 |
|
Claire Zhu, Ph.D. |
| Ogilvie, Gina |
University Of British Columbia
United States |
Addressing emerging health system priorities in cervical cancer prevention: determining optimal strategies for human papillomavirus test-based screening and triage |
5R01CA221918-05 |
|
Claire Zhu, Ph.D. |
| Carlsson, Sigrid |
Sloan-Kettering Inst Can Research
United States |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
5U01CA266535-02 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |